View clinical trials related to Cancer of Mouth.
Filter by:This study will examine the combination of pembrolizumab and tadalafil for safety and efficacy in advanced head and neck cancer.
This study will assess the benefit of postoperative adjuvant radiotherapy in patients with an early oral squamous cell carcinoma (OSCC) having tumor thickness more than or equal to 5mm. The study population will consist of patients who have been treated by surgery for early stage oral tongue cancers. Patients with a close or positive margin (</= 5mm) and or with metastatic neck node(s) will be excluded. Selected patients will be randomized into two groups. The group I will be observed after surgery and group II will receive adjuvant radiotherapy as per protocol.
uPAR PET/CT for Staging Advanced and Localised oral and oropharyngeal cancer